O

OssDsign AB
STO:OSSD

Watchlist Manager
OssDsign AB
STO:OSSD
Watchlist
Price: 8.05 SEK 1.26% Market Closed
Market Cap: 786.2m SEK
Have any thoughts about
OssDsign AB?
Write Note

OssDsign AB
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

OssDsign AB
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
O
OssDsign AB
STO:OSSD
Current Portion of Long-Term Debt
kr1.3m
CAGR 3-Years
-26%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Current Portion of Long-Term Debt
kr9.8m
CAGR 3-Years
36%
CAGR 5-Years
24%
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Current Portion of Long-Term Debt
kr190.8m
CAGR 3-Years
170%
CAGR 5-Years
64%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Current Portion of Long-Term Debt
€3.2m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Current Portion of Long-Term Debt
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

OssDsign AB
Glance View

Market Cap
786.2m SEK
Industry
Health Care

OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.

OSSD Intrinsic Value
10.3 SEK
Undervaluation 22%
Intrinsic Value
Price
O

See Also

What is OssDsign AB's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
1.3m SEK

Based on the financial report for Dec 31, 2023, OssDsign AB's Current Portion of Long-Term Debt amounts to 1.3m SEK.

What is OssDsign AB's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-11%

Over the last year, the Current Portion of Long-Term Debt growth was -57%. The average annual Current Portion of Long-Term Debt growth rates for OssDsign AB have been -26% over the past three years , -11% over the past five years .

Back to Top